(Q39714205)

14 September 2017

title

Achieving cholesterol target in a managed care organization (ACTION) trial (English)

1 reference

14 September 2017

Robert J Straka

1

1 reference

14 September 2017

Reza Taheri

series ordinal

2

1 reference

14 September 2017

Susan L Cooper

series ordinal

3

1 reference

14 September 2017

James C Smith

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

14 September 2017

1 reference

14 September 2017

volume

25

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

360-371

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Serum cholesterol levels are underevaluated and undertreated

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Assessment of hypercholesterolemia control in a managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Efforts to improve compliance with the National Cholesterol Education Program guidelines. Results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Effect of physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.3.360.61601

10.1592/PHCO.25.3.360.61601

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference